-
公开(公告)号:US20190100512A1
公开(公告)日:2019-04-04
申请号:US15537331
申请日:2015-12-15
申请人: Celgene Corporation
发明人: Hon-Wah MAN , Timothy D. FITZPATRICK , Anthony FRANK , Ying LI , Xiaoling LU , Marie G. BEAUCHAMPS , Antonio C. FERRETTI
IPC分类号: C07D403/10 , A61P35/00
摘要: Provided herein are compositions including the crystalline forms of (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b] azepine-4-carboxamide (“Compound A”), methods of making the crystalline forms, and methods of using the crystalline forms for the treatment of diseases, including, for example, cancer.
-
公开(公告)号:US20200002316A1
公开(公告)日:2020-01-02
申请号:US16570191
申请日:2019-09-13
申请人: Celgene Corporation
发明人: Hon-Wah MAN , Timothy D. FITZPATRICK , Anthony FRANK , Ying LI , Xiaoling LU , Marie G. BEAUCHAMPS , Antonio C. FERRETTI
IPC分类号: C07D403/10 , A61P35/00
摘要: Provided herein are compositions including the crystalline forms of (1E, 4E)-2-amino-N,N-dipropyl-8-(4-(pyrrolidine-1-carbonyl)phenyl)-3H-benzo[b]azepine-4-carboxamide (“Compound A”), methods of making the crystalline forms, and methods of using the crystalline forms for the treatment of diseases, including, for example, cancer.
-